Skip to content

Continuous Vs Intermittent Non Invasive Blood Pressure Monitoring in Preventing Post Operative Organ Failure

Continuous Vs Intermittent Non Invasive Blood Pressure Monitoring in Preventing Post Operative Organ Failure

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05496322
Acronym
NiMon
Enrollment
1267
Registered
2022-08-11
Start date
2023-01-26
Completion date
2025-07-01
Last updated
2026-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure Determination, Hemodynamic Monitoring, Postoperative Complications

Keywords

Volume clamp, Continuous non invasive blood pressure monitoring

Brief summary

Continuous non-invasive arterial pressure monitoring has the potential to decrease the duration of intraoperative hypotension and hypertension compared to conventional intermittent blood pressure monitoring. Chen et al. demonstrated using continuous non-invasive arterial pressure devices for every hour of surgery it is possible to identify an average of 14 minutes of potentially treatable hypotensive and hypertensive time(12). Whether the ability to detect more hypotension events by continuous non-invasive arterial pressure monitoring use can improve patient outcomes, is still an open research question

Interventions

DEVICEContinuous Non Invasive Blood Pressure Monitoring

Continuous non-invasive arterial pressure monitoring

DEVICEIntermittent Non Invasive Blood Pressure Monitoring

Intermittent non-invasive arterial pressure monitoring

Sponsors

University of Messina
Lead SponsorOTHER
Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All adult (age ≥18 years) patients scheduled for elective non-cardiac surgery in participating centers * Surgical case planned with non invasive blood pressure monitoring according to local clinical practice or policies.

Exclusion criteria

* Missing of preoperative serum creatinine during 30 days prior surgery * Preoperative dialysis * Chronic kidney disease (eGFR \< 60ml/min Cockcroft-Gault equation) * Surgical procedure lasting less than 60 min * Planned use of permissive hypotension * Urological procedures (including nephrectomy and renal transplantation) * Refusal to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Post operative myocardial injury1 weekThe primary outcome will be the proportions of myocardial injury (Definitions: elevation of serum Troponin T (TnT) \>= 30 ng/L in the first post-operative week)

Secondary

MeasureTime frameDescription
Post operative Acute kidney injury1 weekProportions of postoperative AKI (Definition: increase in postoperative serum creatinine concentration during the first 7 postoperative days by more than 1.5-fold or greater than 0.3 mg/dl. Preoperative concentration was defined as the most recent recorded measurement within 30 days before the surgery)
Post operative death28 day after surgeryDeath during postoperative hospital stay
Events 30d post surgery30 days after surgeryAny of the following events after surgery: Stroke, Non fatal cardiac arrest, AKI stage 2-3, Sepsis, Death)
Events 90d post surgery90 days after surgeryAny of the following events after surgery: Stroke, Non fatal cardiac arrest, AKI stage 2-3, Sepsis, Death)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026